immune system
|
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
|
|
• plasmablast numbers in spleen are increased relative to wild-type
|
|
• higher numbers of T2 B cells in spleen relative to wild-type
|
|
• higher in spleen relative to wild-type
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• T1:follicular B cell ratio is higher than wild-type or Bcl2l11-deficient mice
|
|
• total number of CD19+ splenocytes is higher than wild-type
• total number of splenocytes is increased relative to wild-type
|
|
• continuous treatment with recombinant murine IL12 results in sustained recruitment of NK cells to the liver
|
|
• mice develop less severe lymphadenopathy at later ages than the double mutant Igh-6/Fas mice
|
|
• total number of cells per lymph node is increased compared to wild-type
|
|
• total anti-IgM antibody levels are increased compared to wild-type
|
|
• anti-nuclear antibodies are increased compared to wild-type
|
|
• anti-ssDNA IgM and IgG antibodies are increased compared to wild-type
|
|
• increased compared to wild-type
|
|
• anti-ssDNA IgM and IgG antibodies are increased compared to wild-type
|
|
• by 7 days after TMEV infection, inflammation is present, decreasing slightly by 21 days, but widespread tissue damage is present, similar to controls (B6)
• tissue damage is less frequent at 45 days than in Prf-null mice
|
|
• mice infected with 500 CFU of S. aureus have drastically elevated number of S. aureus CFU compared to similarly-infected wild-type mice, but lower counts than infected Faslgld mice
|
|
• inflammation and tissue damage in the brain are slightly greater than in control, resistant mice at 45 and 180 days
|
hematopoietic system
|
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
|
|
• plasmablast numbers in spleen are increased relative to wild-type
|
|
• higher numbers of T2 B cells in spleen relative to wild-type
|
|
• higher in spleen relative to wild-type
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• T1:follicular B cell ratio is higher than wild-type or Bcl2l11-deficient mice
|
|
• total number of CD19+ splenocytes is higher than wild-type
• total number of splenocytes is increased relative to wild-type
|
|
• continuous treatment with recombinant murine IL12 results in sustained recruitment of NK cells to the liver
|
renal/urinary system
|
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type
|
|
• number of macrophages surrounding glomeruli is increased compared to wild-type which have no macrophage index
|
|
• IgG deposits mainly localized to glomerular basement membrane are increased relative to wild-type
|
liver/biliary system
|
• confluent foci of feathery hepatocyte degeneration due to bile acid cytotoxicity are significantly reduced compared to controls hours after BDL
|
|
• necroinflammatory foci after BDL are reduced in number compared to controls
|
|
• when mice are recipients of wild-type hepatitis B surface antigen (HBsAg)-specific Th1 cells after treatment with HBsAg, severe liver injury is induced to similar extent as in wild-type mice
(J:120559)
• treatment with Prf1-deficient HBsAg-specific Th1 cells and HBsAg induces liver injury as severe as that induced by wild-type HBsAg-specific Th1 cells
(J:120559)
• after BDL, necroinflammatory foci and lymphocytic infiltration are obviously less than in controls
(J:135830)
|
|
• hepatocyte cell death is reduced compared to controls after BDL
|
nervous system
|
• by 7 days after TMEV infection, inflammation is present, decreasing slightly by 21 days, but widespread tissue damage is present, similar to controls (B6)
• tissue damage is less frequent at 45 days than in Prf-null mice
|
|
• by 7 days after TMEV infection, inflammation is present in the meninges and gray matter of spinal cord, but decreases by 21 days, although not as much as in controls (B6)
|
cellular
|
• after bile duct ligation (BDL), Peyer's patch B cells do not display evidence of apoptosis
|
|
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type
|
|
• hepatocyte cell death is reduced compared to controls after BDL
|


Analysis Tools